1. Specifically designed for prostate cancer patients, it covers DNA repair (HRD, MMR and other genes), cell cycle, AR, PI3K, WNT and other pathways, and selects genes related to the occurrence, development, targeted therapy and drug resistance of prostate cancer.
2. The tissue version of ProstateCore is used for 1000x high-depth sequencing, while the blood version is used for 10000X ultra-deep sequencing, which exceeded the traditional methods in sensitivity and specificity
Patients with prostate cancer who need molecular diagnostic information to help develop treatment plans and want to understand their family's genetic risk.